Loading candles…
Sanofi India Limited is a multinational pharmaceutical company operating in India within the pharmaceuticals and healthcare industries. The company focuses on medicines addressing Diabetes, Cardiology, Thrombosis, Central Nervous System disorders, and Anti-histamines. It serves as a strategic manufacturing and marketing hub for its global parent company, Sanofi. Its business segments include Diabetes Care, Cardiology, Thrombosis, Central Nervous System, Anti-histamines, and Pain Management. Sanofi India includes the subsidiary Sanofi Consumer Healthcare India Limited, which was formed as a separate entity in fiscal year 2024 following the transition of its Consumer Healthcare business. The company operates a GMP-compliant manufacturing facility in Goa and maintains a distribution network that reaches approximately 100,000 pharmacies across India.
| Unaudited Results - FY26 | To consider and approve the unaudited financial results for the period ended March 31, 2026 | 28 Apr 2026 |
| Audited Results - Q3 & FY25 | To consider and approve the Audited Financial Results and Statements for the Quarter and Financial Year ended 31st December 2025 and Recommendation of Final … | 25 Feb 2026 |
| Unaudited Results - Q1 & FY25 | Board Meeting Intimation for consideration and approval of the Unaudited Financial Statements for the quarter and half-year ended 30th June 2025 | 31 Jul 2025 |
| Unaudited Results - Q4-FY25 | The meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 14th May 2025, inter-alia to consider and approve the Unaudited Fi… | 14 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.